Office of the Director, National Institutes of Health; Notice of Meeting, 80667 [2016-27463]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 221 / Wednesday, November 16, 2016 / Notices
Æ
Æ
Æ
Æ
Æ
Æ
•
Æ
Æ
Æ
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Selection of potential facilities will be
based on the priorities developed for
OPQ staff training, the facility’s current
regulatory status with FDA, and on
consultation with the appropriate FDA
district office. All travel expenses
associated with this program will be the
responsibility of OPQ; therefore,
selection will be based on the
availability of funds and resources for
the fiscal year. OPQ will not provide
financial compensation to the
pharmaceutical site as part of this
program.
IV. Proposals for Participation
Companies interested in offering a site
visit or learning more about this site
visit program should respond by
submitting a proposal directly to Janet
Wilson (see the DATES and FOR FURTHER
INFORMATION CONTACT sections of this
document for more information). To aid
in OPQ’s site selection, your proposal
should include the following
information:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
• A contact person
• Site visit location(s)
• Facility Establishment Identifier and
DUNS numbers, as applicable
• Maximum number of OPQ staff that
can be accommodated during a site
visit, and
• A sample agenda outlining the
proposed learning objectives and
associated activities for the site visit
Proposals submitted without this
minimum information will not be
considered. Based on response rate and
type of responses, OPQ may or may not
consider alternative pathways to
meeting our training goals.
BILLING CODE 4164–01–P
VerDate Sep<11>2014
16:23 Nov 15, 2016
Jkt 241001
Dated: November 9, 2016.
Anna Snouffer
Deputy Director, Office of Federal Advisory
Committee Policy.
Office of the Director, National
Institutes of Health; Notice of Meeting
III. Site Selection
[FR Doc. 2016–27454 Filed 11–15–16; 8:45 am]
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
National Institutes of Health
Hot melt extrusion processes
Soft-gel encapsulation processes
Lyophilization processes
Blow-Fill-Seal and isolators
Spray-drying processes
Process analytical technology and
Real Time Release Testing
Emerging technologies
Continuous manufacturing
3-dimensional printing
Nanotechnology
Dated: November 9, 2016.
Peter Lurie,
Associate Commissioner for Public Health
Strategy and Analysis.
80667
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 8, 2016.
Time: 9:00 a.m. to 5:15 p.m.
Agenda: NIH Director’s Report, ACD
Working Group Reports.
Place: National Institutes of Health,
Building 31, 6th Floor Conference Room 6C,
31 Center Drive, Bethesda, MD 20892.
Date: December 9, 2016.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: Other business of the Committee.
Place: National Institutes of Health,
Building 31, 6th Floor Conference Room 6C,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, Woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the Office
of the Director, National Institutes of Health,
home page: https://acd.od.nih.gov, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
[FR Doc. 2016–27463 Filed 11–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiovascular Sciences.
Date: November 30–December 1, 2016.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4128,
Bethesda, MD 20892, 301–435–1850, limc4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiovascular and Respiratory
Special Emphasis Panel.
Date: December 7, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Olga A Tjurmina, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 451–
1375, ot3d@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory Sciences.
Date: December 7–8, 2016.
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 81, Number 221 (Wednesday, November 16, 2016)]
[Notices]
[Page 80667]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27463]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Advisory Committee to the Director, National Institutes of Health.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: December 8, 2016.
Time: 9:00 a.m. to 5:15 p.m.
Agenda: NIH Director's Report, ACD Working Group Reports.
Place: National Institutes of Health, Building 31, 6th Floor
Conference Room 6C, 31 Center Drive, Bethesda, MD 20892.
Date: December 9, 2016.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: Other business of the Committee.
Place: National Institutes of Health, Building 31, 6th Floor
Conference Room 6C, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892, 301-496-4272,
Woodgs@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Office of the Director,
National Institutes of Health, home page: https://acd.od.nih.gov,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: November 9, 2016.
Anna Snouffer
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27463 Filed 11-15-16; 8:45 am]
BILLING CODE 4140-01-P
